Ranexa
- Product NDC
- 61958-1004
- 11-digit product format
- 619581004
- Labeler code
- 61958
- Product ID
- 61958-1004_ba1f4469-5e3c-447a-9d28-8e57a2c32a17
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- RANOLAZINE
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- Gilead Sciences, Inc.
- Application
- NDA021526
- Marketing category
- NDA
- Marketing start
- 2007-02-12
- Marketing end
- 0000-00-00
- Substance
- RANOLAZINE
- Active strength
- 1000 mg/1
- Pharmacologic classes
- Anti-anginal [EPC],Cytochrome P450 3A Inhibitors [MoA],P-Glycoprotein Inhibitors [MoA],Cytochrome P450 2D6 Inhibitors [MoA],Organic Cation Transporter 2 Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 61958-1004-1 | 61958100401 | 60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (61958-1004-1) | 2007-02-12 | 0000-00-00 | No | No | Current |
| 61958-1004-2 | 61958100402 | 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE, PLASTIC (61958-1004-2) | 2007-02-12 | 0000-00-00 | No | No | Current |
| 61958-1004-3 | 61958100403 | 14 TABLET, FILM COATED, EXTENDED RELEASE in 1 BLISTER PACK (61958-1004-3) | 2007-02-12 | 0000-00-00 | No | No | Current |